药品注册申请号:022020
申请类型:NDA (新药申请)
申请人:WYETH PHARMS
申请人全名:WYETH PHARMACEUTICALS LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 PROTONIX PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 40MG BASE Yes Yes AB 2007/11/14 2007/11/14 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/07/18 SUPPL-23(补充) Approval Labeling STANDARD
2022/03/04 SUPPL-21(补充) Approval Labeling STANDARD
2020/11/27 SUPPL-18(补充) Approval Labeling STANDARD
2019/04/25 SUPPL-17(补充) Approval Labeling STANDARD
2018/06/07 SUPPL-16(补充) Approval Labeling STANDARD
2017/12/20 SUPPL-13(补充) Approval Labeling STANDARD
2017/12/06 SUPPL-14(补充) Approval Labeling STANDARD
2017/07/06 SUPPL-15(补充) Approval Labeling STANDARD
2016/10/24 SUPPL-12(补充) Approval Labeling STANDARD
2014/12/19 SUPPL-11(补充) Approval Labeling 901 REQUIRED
2013/12/10 SUPPL-10(补充) Approval Labeling STANDARD
2012/10/09 SUPPL-6(补充) Approval Labeling STANDARD
2012/05/11 SUPPL-7(补充) Approval Labeling STANDARD
2011/10/31 SUPPL-4(补充) Approval Labeling UNKNOWN
2011/05/20 SUPPL-5(补充) Approval Labeling UNKNOWN
2010/09/03 SUPPL-3(补充) Approval Labeling 901 REQUIRED
2009/11/12 SUPPL-2(补充) Approval Labeling STANDARD
2007/11/14 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
001 7544370 2026/06/07 Y PDF格式
7544370*PED 2026/12/07 PDF格式
7550153 2024/09/30 U-859 PDF格式
7550153*PED 2025/03/30 PDF格式
7553498 2024/09/30 U-859 PDF格式
7553498*PED 2025/03/30 PDF格式
7838027 2024/09/30 Y U-859 PDF格式
7838027*PED 2025/03/30 PDF格式
001 4758579 2010/07/19 Y Y U-859 PDF格式**本条是由Drugfuture回溯的历史信息**
4758579*PED 2011/01/19 PDF格式**本条是由Drugfuture回溯的历史信息**
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:PANTOPRAZOLE SODIUM 剂型/给药途径:FOR SUSPENSION, DELAYED RELEASE;ORAL 规格:EQ 40MG BASE 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022020 001 NDA PROTONIX PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 40MG BASE Prescription Yes Yes AB 2007/11/14 WYETH PHARMS
213725 001 ANDA PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 40MG BASE Prescription No No AB 2020/06/30 SUN PHARM
217416 001 ANDA PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 40MG BASE Prescription No No AB 2023/02/09 AJANTA PHARMA LTD
216247 001 ANDA PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 40MG BASE Prescription No No AB 2023/06/16 DEXCEL
216139 001 ANDA PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 40MG BASE Prescription No No AB 2023/10/27 ANNORA PHARMA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database